Gene Im

@geneyim

Transplant Hepatologist and Director of the Advanced Interdisciplinary Alcohol Liver Program and Treatment (ADAPT) at Columbia University

New York City

Joined August 2011

497Following

1KFollowers

Gene Im@geneyim · Jun 25

"Revisiting" HBV vaccination opens up extraordinary and unnecessary risk for Americans. nytimes.com/2025/06/25/hea…

geneyim's tweet card. The reconstituted C.D.C. panel will revisit the standard vaccination schedule. The former head of an anti-vaccine group is now a special federal employee.

431

Gene Im@geneyim · Jun 24

Thanks Jonathan for your collaboration on this large survey effort. Sometimes it takes 19 coauthors to do a nationwide survey of >300 providers from 44 states! Is the GI/Hep community ready to take ownership of prescribing wt loss meds (GLP-1s) for our patients with MASLD?

JJonathan G. Stine, MD MSc, FACP@JonathanStineMD · Jun 24

New national survey of hepatology & GI providers: Despite 96% believing weight loss meds help #MASLD, 77% rarely/never prescribe them due to low comfort & limited training. Hunge thanks to @geneyim @MeenaBBansal for leading this effort 👉 journals.lww.com/jcge/abstract/…

618

Gene Im@geneyim · Jun 23

How does transient elastography (TE) ⬇️alcohol use? In our new study, @sm_rutledge & @ronathaniMD examined potential mechanisms behind this & found that TE ⬆️readiness for change. Start thinking of TE as a #theranostic intervention. doi.org/10.1111/adb.70… @Echosens

geneyim's tweet card. In this prospective, proof-of-concept pilot study of transient elastography as an opportunistic intervention in patients admitted to an addiction unit by assessing changes in validated psychometric...

2.0K

Gene Im@geneyim · Jun 9

Great synopsis Hanna! 1 unresolved question is what proportion of pts with MetALD have co-occurring alcohol use disorder? The answer will inform a lot: definition validity, appropriate alcohol treatment, clinical trial design, etc. My guess: it's high w/ most MetALD being ALD.

HHanna Blaney, MD, MPH@BlaneyMD · Jun 9

I’ve learned a lot from @geneyim and others about MetALD. 🆕 term/ICD 10 code ➡️Most adults in US have metabolic risk factors ➡️Lots of patients drink more than 1-2 🍷🍸/day and/or binge drink ❌Not all have MetALD ❓Is it metabolic factors or 🍸driving disease progression? ⚖️

734

Gene Im@geneyim · Jun 6

Dismayed seeing this ALERT when visiting the great @NIAAAnews alcohol treatment navigator website that our team uses daily to connect patients to alcohol care. Federal funding cuts hurt patients, especially the most vulnerable.

geneyim's tweet image. Dismayed seeing this ALERT when visiting the great @NIAAAnews alcohol treatment navigator website that our team uses daily to connect patients to alcohol care.

Federal funding cuts hurt patients, especially the most vulnerable.

577

Gene Im@geneyim · Jun 5

New pet-peeve unlocked: a conference on steatotic liver disease (SLD) with no mention of alcohol 😬

379

Gene Im@geneyim · May 3

En route to San Diego for #DDW2025 with some AASLD swag Excited to represent @AASLDtweets at a few sessions on MetALD and AH. See you there!

geneyim's tweet image. En route to San Diego for #DDW2025 with some AASLD swag

Excited to represent @AASLDtweets at a few sessions on MetALD and AH. See you there!

1.0K

Gene Im@geneyim · Apr 8

Congratulations @JoeCullaro on this eye-opening study! @ColumbiaMed @NYC_Tx_Hep

HHEPATOLOGY Journal@HEP_Journal · Apr 8

Original Article The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: a post hoc analysis Cullaro et al. #LiverX tinyurl.com/2pe5uasn

661

Gene Im@geneyim · Apr 5

Patient advocate Jenn Jones @SoberLivers leading a panel on the Future on ALD care at @ALD_ALLY Thank you for sharing your voice!

geneyim's tweet image. Patient advocate Jenn Jones @SoberLivers leading a panel on the Future on ALD care at @ALD_ALLY
Thank you for sharing your voice!

251

Gene Im@geneyim · Apr 5

The attendees at @ALD_ALLY were the real stars @ALD_ALLY. Great discussions and interactions all day. Thank you What a group!

7.0K

Gene Im@geneyim · Apr 5

Thanks to our All-Star panel of speakers at @ALD_ALLY. A great day of insights and actionable initiatives.

2.0K

Gene Im@geneyim · Apr 4

Incredible panel of world-class experts discussing MetALD at @ALD_ALLY @NoureddinMD @DrLoomba @serperm Hannes Hagstrom @AsraniSumeet

geneyim's tweet image. Incredible panel of world-class experts discussing MetALD at @ALD_ALLY

@NoureddinMD
@DrLoomba
@serperm
Hannes Hagstrom
@AsraniSumeet

2.0K

Gene Im@geneyim · Apr 4

Potential MetALD pharmacotherapies talk by @DrLoomba at @ALD_ALLY @UCSDHealth

2.0K

Gene Im@geneyim · Apr 4

Minimum unit pricing and Alcohol policies to improve health by @AsraniSumeet at @ALD_ALLY

194

Gene Im@geneyim · Apr 4

Alexandre Louvet discusses clinical trial design in AH and ALD @ALD_ALLY

219

Gene Im@geneyim · Apr 4

High impact studies in ALD in the past year -moving the field forward by @juanpabloarab at @ALD_ALLY @VCU_Liver

859

Gene Im@geneyim · Apr 4

Optimizing treatment of AUD in ALD by @LiverPsych at @ALD_ALLY meeting

187

Gene Im@geneyim · Apr 4

Using implementation science to improve ALD care by Shari Rogal @ALD_ALLY meeting

126

Gene Im@geneyim · Apr 4

Excellent talk on Early Detection Strategies for ALD by @serperm at @ALD_ALLY The denominator of pts with ALD also include those not engaged in care

geneyim's tweet image. Excellent talk on Early Detection Strategies for ALD by @serperm at @ALD_ALLY

The denominator of pts with ALD also include those not engaged in care

177

Gene Im@geneyim · Apr 3

It’s almost here…still a few seats left for all the procrastinators out there See you tomorrow bright and early @ALD_ALLY #NYC

GGene Im@geneyim · Jan 6

I'm so excited to introduce ALD-ALLY, a new Alcohol Liver Disease Conference in NYC on April 4, 2025 ALD-ALLY is a call to action for advancing the science & care of pts with ALD. In-person, small group discussions with world class experts! Register at ald-ally.com

728